ADAPTIMMUNE THERAPEUTICS PLC's ticker is and the CUSIP is 00653A907. A total of 3 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $156 | -99.2% | 200 | -99.0% | 0.00% | – |
| Q2 2023 | $19,055 | -69.8% | 20,600 | -52.3% | 0.00% | – |
| Q4 2022 | $63,072 | +16.8% | 43,200 | -13.6% | 0.00% | – |
| Q3 2022 | $54,000 | -50.5% | 50,000 | -22.2% | 0.00% | – |
| Q2 2022 | $109,000 | -14.2% | 64,300 | +4.2% | 0.00% | – |
| Q1 2022 | $127,000 | -72.5% | 61,700 | -49.9% | 0.00% | – |
| Q4 2021 | $462,000 | -1.3% | 123,200 | +36.0% | 0.00% | -100.0% |
| Q3 2021 | $468,000 | +392.6% | 90,600 | +306.3% | 0.00% | – |
| Q2 2021 | $95,000 | +102.1% | 22,300 | +150.6% | 0.00% | – |
| Q1 2021 | $47,000 | +370.0% | 8,900 | +368.4% | 0.00% | – |
| Q4 2020 | $10,000 | -82.5% | 1,900 | -73.2% | 0.00% | – |
| Q3 2020 | $57,000 | -82.7% | 7,100 | -78.5% | 0.00% | -100.0% |
| Q2 2020 | $330,000 | +217.3% | 33,000 | -13.4% | 0.00% | +100.0% |
| Q1 2020 | $104,000 | +258.6% | 38,100 | +100.5% | 0.00% | – |
| Q3 2019 | $29,000 | -65.9% | 19,000 | -10.0% | 0.00% | -100.0% |
| Q2 2019 | $85,000 | -58.7% | 21,100 | -41.2% | 0.00% | -50.0% |
| Q4 2018 | $206,000 | +6766.7% | 35,900 | +17850.0% | 0.00% | – |
| Q3 2018 | $3,000 | -96.7% | 200 | -97.4% | 0.00% | -100.0% |
| Q2 2018 | $90,000 | +309.1% | 7,600 | +280.0% | 0.00% | – |
| Q1 2018 | $22,000 | +2100.0% | 2,000 | +900.0% | 0.00% | – |
| Q2 2017 | $1,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 200 | $156 | 0.00% |
| SIMPLEX TRADING, LLC | 700 | $0 | 0.00% |